Dose Escalation Study of AST-OPC1 in Spinal Cord Injury

NCT02302157 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Spinal Cord Injury
Spine Injury
Spinal Cord Trauma

Interventions

BIOLOGICAL: AST-OPC1

Sponsor

Lineage Cell Therapeutics, Inc.